awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38214511-5E50F459-F070-47CC-B37F-C578FE60A46B
Q38214511-5E50F459-F070-47CC-B37F-C578FE60A46B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38214511-5E50F459-F070-47CC-B37F-C578FE60A46B
Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer.
P2860
Q38214511-5E50F459-F070-47CC-B37F-C578FE60A46B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38214511-5E50F459-F070-47CC-B37F-C578FE60A46B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e5214cb3e5955f018ebf6669abc68de293a0371
P2860
MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.